These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20740717)

  • 41. [An influence of mexidol on the restoration of neurological deficit, increase of social adaptation and removal of neglect and push syndromes in stroke patients].
    Koval'chuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):52-7. PubMed ID: 22792750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antioxidants in complex treatment of Parkinson's disease].
    Katunina EA; Malykhina EA; Kuznetsov NV; Avakian GN; Gusev Ei; nerobkova LN; Voronina TA; Barskov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):22-8. PubMed ID: 17069058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of mexidol on oral soft tissues in dental pathology].
    Lemetskaia TI; Ssukhova TV; Petrovich IuA
    Stomatologiia (Mosk); 2008; 87(6):31-5. PubMed ID: 19209390
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of mexidol on oxidative stress in cerebral variant of hypertensive crisis].
    Golikov AP; Golikov PP; Davydov BV; Riabinin VA; Luk'ianov MM; Kalinin AN; Klychnikova EV; Promanenkov VK
    Kardiologiia; 2002; 42(3):25-9. PubMed ID: 12494182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis].
    Katunina EA
    Eksp Klin Farmakol; 2005; 68(5):16-8. PubMed ID: 16277203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The use of mexidol in chronic cerebral ischemia].
    Lyang OV; Kochetov AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):126-9. PubMed ID: 24596977
    [No Abstract]   [Full Text] [Related]  

  • 47. [Xerostomia. Diagnosis and treatment].
    Afanas'ev VV; Irmiiaev AA
    Stomatologiia (Mosk); 2004; 83(6):36-8. PubMed ID: 15602471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome].
    Volchegorskiĭ IA; Alekseev MN; Volchegorskaia MI; Rassokhina LM
    Klin Med (Mosk); 2008; 86(10):52-9. PubMed ID: 19069461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The treatment of patients with toxic encephalopathy caused by using surrogate psychoactive manganese-containing compounds].
    Ismailova TF; Fedorova NV; Savchenko LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(12):18-21. PubMed ID: 16447561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The influence of 3-oxypyridine antioxidants on depression in patients with diabetes mellitus].
    Volchegorskiĭ IA; Mester NV
    Klin Med (Mosk); 2007; 85(2):40-5. PubMed ID: 17520888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adaptogenic effects of mexidol in chronic cerebral ischemia].
    Antipenko EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):44-9. PubMed ID: 22677755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined administration of mexidol with known medicines].
    Voronina TA; Ivanova EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(4):115-124. PubMed ID: 31156232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of mexidol in stomatology: results and perspectives].
    Petrovich IuA; Sukhova TV; Lemetskaia TI
    Stomatologiia (Mosk); 2004; 83(6):17-22. PubMed ID: 15609456
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of emoxypine on myocardial electrical instability and homeostasis parameters in patients with acute disturbance of cerebrovascular circulation].
    Stoliarova VV
    Eksp Klin Farmakol; 2002; 65(3):13-5. PubMed ID: 12227086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antihypoxic and antinecrotic effect of mexidol in skin ischemia.
    Galenko-Yaroshevskii VP; Bagmetova EN; Fil'chukova IA; Sidel'nikov AY; Popkov VA; Gorelashvili AS; Antelava NA; Sukoyan GV
    Bull Exp Biol Med; 2005 Feb; 139(2):202-6. PubMed ID: 16027807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antioxidant therapy in combined treatment of postoperative intestinal paresis].
    Magomedov MA
    Khirurgiia (Mosk); 2004; (1):43-5. PubMed ID: 14983163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mexidol preparation influence upon lipids peroxide oxidation and oral fluid antioxidant system activity in patients with chronic generalized parodontitis and arterial hypertension].
    Kazarina LN; Vdovina LV; Dubrovskaia EN
    Stomatologiia (Mosk); 2010; 89(2):18-21. PubMed ID: 20517245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [On the mechanism of antimotion sickness effects of mexidol].
    Motin VG; Iasnetsov VV
    Aviakosm Ekolog Med; 2010; 44(1):64-6. PubMed ID: 20804002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The use of mexidol in urgent treatment of drug addiction].
    Klindukhova OI; Novgorodov OE; Sergienko NN; Daniliuk PV; Belotserkovich OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(11):42-5. PubMed ID: 17176602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.